middle.news
Why Patrys’ Acquisition of Reliis Could Redefine Its Biotech Future
8:02pm on Thursday 26th of February, 2026 AEDT
•
Biotechnology
Read Story
Why Patrys’ Acquisition of Reliis Could Redefine Its Biotech Future
8:02pm on Thursday 26th of February, 2026 AEDT
Key Points
Half-year loss nearly doubles to $3.02 million
Completed 15-for-1 share consolidation and raised $1.77 million
Acquisition of Reliis Pty Ltd adds clinical-stage CNS asset RLS-2201
Reduced R&D spend amid restructuring; no R&D tax incentive claimed
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Patrys (ASX:PAB)
OPEN ARTICLE